Picture of Biogened SA logo

BGD — Biogened SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly Speculative

Momentum

Relative Strength (%)
1m+5.96%
3m+25.06%
6m+73.38%
1yr+8.17%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-12.08%
50d MA+7.2%
200d MA+27.63%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS  /

Blurred out image of Biogened SA EPS forecast chart

Profile Summary

Biogened SA is a Poland-based company active in the healthcare sector. The Company is engaged in production and distribution of generic pharmaceuticals in psychiatry, neurology and oncology, as well as development, production and distribution of dermocosmetics and diet supplements. The Company’s product portfolio includes: Polmantis and SST Salvia Stimulating Tablets (pharmaceuticals), Dermedic, Ellexir, Herba Botanic and Novoscabin (dermocosmetics), and Fibers, Prolady, Futimal and Dermedic Caps (diet supplemenst). As of March 31, 2012, Life Science Technologies NV held an 80.92% stake in the capital.

Directors

Last Annual
Last Interim
Incorporated
February 1st, 2007
Public Since
August 31st, 2011
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
2,456,319

BGD Share Price Performance

Upcoming Events for BGD

Biogened SA Annual Shareholders Meeting

Dividend For BGDP.WA - 0.3000 PLN

Similar to BGD

Picture of Bioceltix SA logo

Bioceltix SA

pl flag iconWarsaw Stock Exchange

Picture of BioMaxima SA logo

BioMaxima SA

pl flag iconWarsaw Stock Exchange

Picture of Cannabis Poland SA logo

Cannabis Poland SA

pl flag iconWarsaw Stock Exchange

Picture of Celon Pharma SA logo

Celon Pharma SA

pl flag iconWarsaw Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email